CDK12 and prostate carcinoma: The gene encoding cyclin dependent kinase 12 (CDK12) is functionally compromised by bi-allelic mutation or copy loss in about 5% of mCRPC cases (and in 1–2% of primary prostate cancers)(1, 9, 10).